Status:

WITHDRAWN

Inflammatory Arthritis and Difficulty at Work

Lead Sponsor:

University of Lorraine

Conditions:

Inflammatory Arthritis

Eligibility:

All Genders

18-65 years

Brief Summary

Despite biologic drugs and improvements of inflammatory arthritis (IA) treatment, many patients with inflammatory arthritis still face increased absenteeism, reduced at-work productivity and report di...

Detailed Description

The development of the patient-reported outcome (PRO) measure will comprise: Step 1: Identifying themes and generating items by * Conducting focus groups and/or individual semi-structured interviews...

Eligibility Criteria

Inclusion

  • Patients
  • Physician diagnosis of IA (rheumatoid arthritis, spondyloarthritis or psoriatic arthritis)
  • Age 18 to 65 years
  • Currently employed
  • Having concerns about their IA at work ("Do you have any concern about your arthritis affecting your ability to work now, or in the next five years?),

Exclusion

  • • Sick leave of more than 3 years
  • Health care professionals (clinicians, nurses experts in therapeutic education, occupational physicians), a vocational counsellor, and professionals of the prevention and security at work, professionals from the pension insurance fund and health at work or professionals involved in accommodation of working conditions for disabled workers

Key Trial Info

Start Date :

October 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 30 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04015960

Start Date

October 1 2019

End Date

July 30 2021

Last Update

June 25 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Université Lorraine

Nancy, France